Pentosan polysulfate decreases proliferation and net extracellular matrix production in mouse mesangial cells

Citation
Sj. Elliot et al., Pentosan polysulfate decreases proliferation and net extracellular matrix production in mouse mesangial cells, J AM S NEPH, 10(1), 1999, pp. 62-68
Citations number
37
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
ISSN journal
10466673 → ACNP
Volume
10
Issue
1
Year of publication
1999
Pages
62 - 68
Database
ISI
SICI code
1046-6673(199901)10:1<62:PPDPAN>2.0.ZU;2-W
Abstract
Glomerulosclerosis is characterized by extracellular matrix accumulation an d is often associated with mesangial cell proliferation. Heparin-like molec ules have been shown to decrease glomerulosclerosis in vivo, although their cellular site and mechanism of action is still unclear. In this study, a l ine of glomerular mesangial cells derived from normal mice was used to dete rmine whether pentosan polysulfate (PPS) inhibited proliferation and altere d extracellular matrix turnover. Cells treated with PPS showed a decrease i n cell number beginning 24 h after treatment, which was maintained for 5 d, For matrix accumulation and degradation studies, cells were treated for 5 d and collagen types I and IV protein were measured by enzyme-linked immuno sorbent assay as well as matrix metalloproteinases (MMP) measured by zymogr aphy. Collagen types I and type IV were significantly decreased in the medi a (P < 0.0001) and cell layer (P < 0.005) after treatment with PPS but not after treatment with heparin. By zymography, MMP-2 was significantly increa sed after treatment with PPS (P < 0.001) and heparin (P < 0.05). PPS and he parin also decreased MMP-9 (P < 0.001) after treatment. Reverse zymography showed the presence of tissue inhibitors of metal-loproteinases (TIMP)-1and -2 in control mesangial cells. Treatment with PPS and heparin increased TI MP-1, Zn addition, TIMP-3 was found in the medium of treated but not contro l cells. In conclusion, PPS alters extracellular matrix turnover through th e induction of MMP-2 and alterations in the TIMP profile and may be useful in decreasing progressive glomerulosclerosis.